California Public Employees Retirement System Has $106.16 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

California Public Employees Retirement System boosted its position in HCA Healthcare, Inc. (NYSE:HCA) by 2.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 353,702 shares of the company’s stock after purchasing an additional 9,015 shares during the period. California Public Employees Retirement System owned about 0.14% of HCA Healthcare worth $106,164,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the business. Whipplewood Advisors LLC acquired a new position in shares of HCA Healthcare in the fourth quarter valued at $31,000. Tidemark LLC acquired a new stake in HCA Healthcare during the fourth quarter worth approximately $36,000. Legacy Investment Solutions LLC bought a new position in shares of HCA Healthcare during the third quarter worth approximately $39,000. Activest Wealth Management boosted its stake in HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after purchasing an additional 125 shares during the period. Finally, Pinnacle Bancorp Inc. lifted its holdings in shares of HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after buying an additional 50 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares in the company, valued at $4,971,757.08. The trade was a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.30% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

HCA has been the subject of several analyst reports. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $380.00 price objective on shares of HCA Healthcare in a report on Tuesday, December 17th. Morgan Stanley reduced their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. Royal Bank of Canada cut their price target on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a report on Monday, January 27th. Truist Financial cut their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Finally, KeyCorp dropped their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Price Performance

HCA opened at $346.08 on Tuesday. The firm has a market cap of $85.20 billion, a price-to-earnings ratio of 15.75, a PEG ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The stock’s 50 day simple moving average is $325.24 and its 200 day simple moving average is $340.60.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the prior year, the firm posted $5.90 EPS. As a group, analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were issued a dividend of $0.72 per share. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.83%. The ex-dividend date was Monday, March 17th. HCA Healthcare’s dividend payout ratio is presently 13.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.